Stay updated on NSCLC Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the NSCLC Immunotherapy Clinical Trial page.

Latest updates to the NSCLC Immunotherapy Clinical Trial page
- Check4 days agoChange DetectedThe trial's location list was updated to drop Qiryat Krinitzi and add Tel Litwinsky in Israel, altering the set of active recruitment sites. This reflects a change in where eligible patients can enroll in the study.SummaryDifference0.0%

- Check11 days agoChange DetectedA new site in Qiryat Krinitzi, Israel (52621) was added to the study locations, and the Tel Litwinsky, Israel (52621) site was removed, altering the enrollment options in Israel.SummaryDifference0.0%

- Check18 days agoChange DetectedThe study record now includes a funding reference: 2014 ( U.S. NIH Grant/Contract ). The page revision has been updated to v3.6.6, replacing the older v3.6.5.SummaryDifference0.0%

- Check33 days agoChange DetectedA new PubMed citation has been added to the Publications section for the study: Nishio M, Hayashi H, Goto Y, et al. Nivolumab plus ipilimumab-based treatment in Japanese patients with metastatic non-small cell lung cancer and tumor PD-L1 < 1%: a pooled analysis. Int J Clin Oncol. 2026 Aug 11. doi: 10.1007/s10147-026-03116-w. Online ahead of print.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision update to v3.6.5 is shown alongside deletions that remove access to study documents, sponsor details, and related terms on the page, altering how the trial's materials and context are presented.SummaryDifference16%

- Check54 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, signaling a small internal update to the page without modifying the displayed study information.SummaryDifference0.0%

Stay in the know with updates to NSCLC Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NSCLC Immunotherapy Clinical Trial page.